Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.

作者信息

Katki Hormuzd A, Gail Mitchell H, Greene Mark H

机构信息

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

出版信息

Lancet Oncol. 2007 Dec;8(12):1042-1043. doi: 10.1016/S1470-2045(07)70348-0.

DOI:10.1016/S1470-2045(07)70348-0

PMID:18054868

Abstract

摘要

相似文献

[1]

Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.

Lancet Oncol. 2007-12

[2]

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

J Clin Oncol. 2009-12-10

[3]

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.

Breast Cancer Res Treat. 2010-1

[4]

BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Fam Cancer. 2006

[5]

Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations.

Ann Surg Oncol. 2009-9-18

[6]

Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.

J Clin Oncol. 2009-12-10

[7]

Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.

Breast Cancer. 2017-3

[8]

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

JAMA Oncol. 2015-6

[9]

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

JAMA Oncol. 2016-6-1

[10]

CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.

Mol Hum Reprod. 2007-4

引用本文的文献

[1]

Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks.

J Natl Cancer Inst. 2018-8-1

[2]

No evidence of excessive cancer screening in female noncarriers from mutation-positive families.

Curr Oncol. 2017-12

[3]

Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.

Mol Med. 2012-12-6

[4]

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec.

Eur J Hum Genet. 2011-1-19

[5]

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.

Breast Cancer Res Treat. 2010-5-11

[6]

Musings on genome medicine: the value of family history.

Genome Med. 2009-8-3

[7]

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.

Health Expect. 2008-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献